Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Werle

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Gastroenterologie Clinique Et Biologique|July 13, 2001
[Current knowledge on chronic hepatitis B therapy]F Zoulim, B Werle
The International Journal of Biological Markers|April 14, 2000
Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancerJ Kos, B Werle, T Lah, et al.
Anticancer Research|January 1, 1996
Charge polymorphism in human lung cell pro-cathepsin BB Werle, W Ebert, W Klein, et al.
International Journal of Oncology|May 12, 2011
Imbalance between cathepsin-B and cysteine proteinase-inhibitors is of prognostic-significance in human lung-cancerH Knoch, B Werle, W Ebert, et al.
Biological Chemistry Hoppe-Seyler|March 1, 1995
Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissueB Werle, W Ebert, W Klein, et al.
Anticancer Research|May 1, 1994
Cathepsin B in tumors, normal tissue and isolated cells from the human lungB Werle, W Ebert, W Klein, et al.
Neoplasma|September 10, 2005
Pleural fluids associated with metastatic lung tumors are rich in progelatinase B/proMMP-9J Kotyza, M Pesek, V Bednárová, et al.
British Journal of Cancer|January 1, 1997
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lungB Werle, B Jülke, T Lah, et al.
Vaccine|August 26, 1999
Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragmentB Werle, C Fromantin, A Alexandre, et al.
Vaccine|July 31, 1998
Immune response to baculovirus expressed protein fragment amino acids 190-289 of respiratory syncytial virus (RSV) fusion proteinB Werle, C Bourgeois, A Alexandre, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Gastroenterologie Clinique Et Biologique|July 13, 2001
[Current knowledge on chronic hepatitis B therapy]F Zoulim, B Werle
The International Journal of Biological Markers|April 14, 2000
Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancerJ Kos, B Werle, T Lah, et al.
Anticancer Research|January 1, 1996
Charge polymorphism in human lung cell pro-cathepsin BB Werle, W Ebert, W Klein, et al.
International Journal of Oncology|May 12, 2011
Imbalance between cathepsin-B and cysteine proteinase-inhibitors is of prognostic-significance in human lung-cancerH Knoch, B Werle, W Ebert, et al.
Biological Chemistry Hoppe-Seyler|March 1, 1995
Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissueB Werle, W Ebert, W Klein, et al.
Anticancer Research|May 1, 1994
Cathepsin B in tumors, normal tissue and isolated cells from the human lungB Werle, W Ebert, W Klein, et al.
Neoplasma|September 10, 2005
Pleural fluids associated with metastatic lung tumors are rich in progelatinase B/proMMP-9J Kotyza, M Pesek, V Bednárová, et al.
British Journal of Cancer|January 1, 1997
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lungB Werle, B Jülke, T Lah, et al.
Vaccine|August 26, 1999
Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragmentB Werle, C Fromantin, A Alexandre, et al.
Vaccine|July 31, 1998
Immune response to baculovirus expressed protein fragment amino acids 190-289 of respiratory syncytial virus (RSV) fusion proteinB Werle, C Bourgeois, A Alexandre, et al.
Pageof 3